NewslettersIntestinal Cell NewsOrganoid NewsThymidine Kinase 1 Mediates the Synergistic Antitumor Activity of Ubenimex and Celecoxib via Regulation of Cell Cycle in Colorectal CancerBy Bob - August 5, 20220235Scientists revealed that ubenimex and/or celecoxib exerted anti–colon cancer effects in vitro and in vivo, and the efficacy was significantly enhanced when the two drugs were combined.[Journal of Pharmacology and Experimental Therapeutics]Abstract